CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

by Eppenberger-Castori Serenella, Schmitt Manfred, Harbeck Nadia, Lewin Jörn, Fassbender Anne, Dietrich Jörn, Krispin Manuel, Dietrich Dimo, Vuaroqueaux Vincent, Spyratos Frédérique, Foekens John A, Lesche Ralf, Martens John WM
Published 2010-06-01